Compare RDY & SPXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDY | SPXC |
|---|---|---|
| Founded | 1984 | 1912 |
| Country | India | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.9B | 10.1B |
| IPO Year | 2001 | 1994 |
| Metric | RDY | SPXC |
|---|---|---|
| Price | $15.32 | $236.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | $16.90 | ★ $245.56 |
| AVG Volume (30 Days) | ★ 1.9M | 640.3K |
| Earning Date | 05-12-2026 | 04-30-2026 |
| Dividend Yield | ★ 0.52% | N/A |
| EPS Growth | N/A | ★ 18.08 |
| EPS | N/A | ★ 1.19 |
| Revenue | N/A | ★ $2,265,100,000.00 |
| Revenue This Year | $7.72 | $16.07 |
| Revenue Next Year | $3.50 | $7.68 |
| P/E Ratio | ★ $18.67 | $205.50 |
| Revenue Growth | N/A | ★ 14.17 |
| 52 Week Low | $12.19 | $165.15 |
| 52 Week High | $15.27 | $251.08 |
| Indicator | RDY | SPXC |
|---|---|---|
| Relative Strength Index (RSI) | 78.69 | 54.94 |
| Support Level | $13.80 | $187.90 |
| Resistance Level | N/A | $245.66 |
| Average True Range (ATR) | 0.29 | 11.24 |
| MACD | 0.23 | -0.01 |
| Stochastic Oscillator | 85.91 | 54.02 |
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
SPX Technologies Inc supplies engineered heating, ventilation, and air conditioning, or HVAC, products, as well as detection and measurement technologies and power equipment. The company operates through two reportable segments. The HVAC segment which generates the majority of the revenue for the company, designs, manufactures, installs, and services cooling products, as well as heating and ventilation products. The Detection and Measurement technologies segment designs, manufactures, and installs underground pipe and cable locators and inspection equipment, bus-fare collection systems, and others. Geographically, the company has its operations in the United States, Canada, China, the United Kingdom, and Others. It derives maximum revenue from United States.